{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:08:02Z","timestamp":1792595282058,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Efforts to develop cost-effective approaches for detecting amyloid pathology in Alzheimer's disease (AD) have gained significant momentum with a focus on biomarker classification. Recent research has explored non-invasive and readily accessible biomarkers, including magnetic resonance imaging (MRI) biomarkers and some AD risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this comprehensive study, we leveraged a diverse dataset, encompassing participants with varying cognitive statuses from multiple sources, including cohorts from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and our in-house Dementia Disease Initiation (DDI) cohort. As brain amyloid plaques have been proposed as sufficient for AD diagnosis, our primary aim was to assess the effectiveness of multimodal biomarkers in identifying amyloid plaques, using deep machine learning methodologies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings underscore the robustness of the utilized methods in detecting amyloid beta positivity across multiple cohorts. Additionally, we investigated the potential of demographic data to enhance MRI-based amyloid detection. Notably, the inclusion of demographic risk factors significantly improved our models' ability to detect amyloid-beta positivity, particularly in early-stage cases, exemplified by an average area under the ROC curve of 0.836 in the unimpaired DDI cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These promising, non-invasive, and cost-effective predictors of MRI biomarkers and demographic variables hold the potential for further refinement through considerations like APOE genotype and plasma markers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2024.1345417","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T04:38:46Z","timestamp":1708922326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts"],"prefix":"10.3389","volume":"16","author":[{"given":"Mostafa","family":"Mehdipour Ghazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Selnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Tim\u00f3n-Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Tecel\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ingala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atle","family":"Bj\u00f8rnerud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn-Eivind","family":"Kirsebom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tormod","family":"Fladby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"638175","DOI":"10.3389\/fnins.2021.638175","article-title":"Combined structural MR and diffusion tensor imaging classify the presence of Alzheimer's disease with the same performance as MR combined with amyloid positron emission tomography: a data integration approach","volume":"15","author":"Agostinho","year":"2022","journal-title":"Front. Neurosci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","article-title":"Clinical core of the Alzheimer's disease neuroimaging initiative: progress and plans","volume":"6","author":"Aisen","year":"2010","journal-title":"Alzheimers Dement"},{"key":"B3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"B4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of \u03b2-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"B7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JAD-170231","article-title":"Detecting at-risk Alzheimer's disease cases","volume":"60","author":"Fladby","year":"2017","journal-title":"J. Alzheimers Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer's disease facts and figures","volume":"18","author":"Gaugler","year":"2022","journal-title":"Alzheimers Dement"},{"key":"B9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neuroimage.2007.07.053","article-title":"Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification","volume":"39","author":"Hua","year":"2008","journal-title":"Neuroimage"},{"key":"B10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack Jr","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Update on hypothetical model of Alzheimer's disease biomarkers","volume":"12","author":"Jack Jr","year":"2013","journal-title":"Lancet Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma \u03b2-amyloid in Alzheimer's disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci. Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer's disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov"},{"key":"B17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.trci.2018.10.003","article-title":"Cerebrospinal fluid neurogranin\/\u03b2-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease","volume":"4","author":"Kirsebom","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B18","doi-asserted-by":"publisher","first-page":"fcac244","DOI":"10.1093\/braincomms\/fcac244","article-title":"Stable cerebrospinal fluid neurogranin and \u03b2-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients","volume":"4","author":"Kirsebom","year":"2022","journal-title":"Brain Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"102387","DOI":"10.1016\/j.nicl.2020.102387","article-title":"Prediction of clinical and biomarker conformed Alzheimer's disease and mild cognitive impairment from multi-feature brain structural MRI using age-correction from a large independent lifespan sample","volume":"28","author":"Li","year":"2020","journal-title":"Neuroimage Clin"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2208.14360","article-title":"FAST-AID brain: fast and accurate segmentation tool using artificial intelligence developed for brain","author":"Mehdipour Ghazi","year":"2022","journal-title":"arXiv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.media.2019.01.004","article-title":"Training recurrent neural networks robust to incomplete data: application to Alzheimer's disease progression modeling","volume":"53","author":"Mehdipour Ghazi","year":"2019","journal-title":"Med. Image Anal"},{"key":"B23","doi-asserted-by":"publisher","first-page":"117460","DOI":"10.1016\/j.neuroimage.2020.117460","article-title":"Robust parametric modeling of Alzheimer's disease progression","volume":"225","author":"Mehdipour Ghazi","year":"2021","journal-title":"Neuroimage"},{"key":"B24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch. Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101837","DOI":"10.1016\/j.nicl.2019.101837","article-title":"Prediction of Alzheimer's disease dementia with MRI beyond the short-term: implications for the design of predictive models","volume":"23","author":"Moscoso","year":"2019","journal-title":"Neuroimage Clin"},{"key":"B26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's disease neuroimaging initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00836-1","article-title":"Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach","volume":"13","author":"Royse","year":"2021","journal-title":"Alzheimers Res. Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fnins.2015.00307","article-title":"Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach","volume":"9","author":"Salvatore","year":"2015","journal-title":"Front. Neurosci"},{"key":"B29","first-page":"36","article-title":"Preclinical, prodromal, and dementia stages of Alzheimer's disease","volume":"15","author":"Scharre","year":"2019","journal-title":"Pract. Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mcn.2018.12.001","article-title":"Biomarkers for tau pathology","volume":"97","author":"Sch\u00f6ll","year":"2019","journal-title":"Mol. Cell. Neurosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3233\/JAD-2012-121603","article-title":"Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment","volume":"33","author":"Selnes","year":"2013","journal-title":"J. Alzheimers Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"20375","DOI":"10.1038\/s41598-021-99794-9","article-title":"Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression","volume":"11","author":"Siafarikas","year":"2021","journal-title":"Sci. Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.neuroimage.2006.02.024","article-title":"Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data","volume":"31","author":"Smith","year":"2006","journal-title":"Neuroimage"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0428-1","article-title":"MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study","volume":"10","author":"Ten Kate","year":"2018","journal-title":"Alzheimers Res. Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"fcab008","DOI":"10.1093\/braincomms\/fcab008","article-title":"Detection of \u03b2-amyloid positivity in Alzheimer's disease neuroimaging initiative participants with demographics, cognition, MRI and plasma biomarkers","volume":"3","author":"Tosun","year":"2021","journal-title":"Brain Commun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"102121","DOI":"10.1016\/j.nicl.2019.102121","article-title":"MRI and cognitive scores complement each other to accurately predict Alzheimer's dementia 2 to 7 years before clinical onset","volume":"25","author":"Zandifar","year":"2020","journal-title":"Neuroimage Clin"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1345417\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T04:38:53Z","timestamp":1708922333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1345417\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":38,"alternative-id":["10.3389\/fnagi.2024.1345417"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1345417","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"article-number":"1345417"}}